LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control

Journal: Nature Cell Biology

Published: 2020-02-03

DOI: 10.1038/s41556-020-0463-6

Affiliations: 19

Authors: 21

Go to article
Institutions Share
Department of Pathology, BIDMC, United States of America (USA) 0.33
Department of Biochemistry and Molecular Biology, MUSC, United States of America (USA) 0.07
F.M. Kirby Neurobiology Center, BCH, United States of America (USA) 0.07
Harvard Department of Neurology, United States of America (USA) 0.07
Department of Medicine, BU, United States of America (USA) 0.05
Department of Pharmacology and Experimental Therapeutics, BU, United States of America (USA) 0.05
Tongji Hospital (TJH), HUST, China 0.05
Harvard Department of Developmental Biology, United States of America (USA) 0.05
Harvard Stem Cell Institute (HSCI), United States of America (USA) 0.05
Horae Gene Therapy Center (GTC), UMass Medical School, United States of America (USA) 0.05
Li Weibo Institute for Rare Diseases Research, UMass Medical School, United States of America (USA) 0.05
UNC Department of Biochemistry and Biophysics, United States of America (USA) 0.02
UNC Lineberger Comprehensive Cancer Center, United States of America (USA) 0.02
Division of Signal Transduction, BIDMC, United States of America (USA) 0.02
Harvard Department of Medicine, United States of America (USA) 0.02
Cancer Research Institute, BIDMC, United States of America (USA) 0.02
Department of Medicine, BIDMC, United States of America (USA) 0.02

Return